• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 29 May 2025

KDST + NLSP Combined Core Investment Case 29052025


CRISPR Therapeutics AG (CRSP:NYSE), 0 | CRISPR Therapeutics AG (CRSP:NAS), 0 | DEXCOM (DXCM:NYSE), 0 | DexCom, Inc. (DXCM:NAS), 0 | Eli Lilly and Co (LLY:NYSE), 0 | Eli Lilly and Company (LLY:NYS), 0 | Hims & Hers Health, Inc. Class A (HIMS:NYS), 0 | INSULET (PODD:NYSE), 0 | Insulet Corporation (PODD:NAS), 0 | Kadimastem Ltd. (KDST:TAE), 0 | Medtronic plc. Ordinary Shares (MDT:NYSE), 0 | Medtronic Plc (MDT:NYS), 0 | NLS Pharmaceutics Ltd. (NLSP:NAS), 0 | Oramed Pharmaceuticals Incorporated (ORMP:TAE), 0 | Sana Biotechnology, Inc. (SANA:NAS), 0 | Sanofi (SAN:EPA), 0 | Sanofi SA (SAN:PAR), 0 | Senseonics Holdings Inc (SENS:NYSE), 0 | Senseonics Holdings, Inc. (SENS:ASE), 0 | Tandem Diabetes Care Inc (TNDM:NYSE), 0 | Tandem Diabetes Care, Inc. (TNDM:NAS), 0 | Teladoc (TDOC:NYSE), 0 | Teladoc Health, Inc. (TDOC:NYS), 0 | Tiziana Life Sciences Ltd. (TLSA:NAS), 0 | VERTEX PHARMACEUTICALS (VRTX:NYSE), 0 | Vertex Pharmaceuticals Incorporated (VRTX:NAS), 0

  • ACF Equity Research
    • Research Team ACF

    • 15 pages


 

We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of merged metrics prior to any synergies. The merger creates a cross-platform pre-revenue biotech with lead programs including a proprietary stem-differentiation platform capable of delivering scalable therapies for replacing lost or damaged cells; IsletRx could revolutionize insulin production for Type 1 diabetes (T1D) patients; AstroRx® targets neurod ....

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

KDST + NLSP Combined Core Investment Case 29052025


CRISPR Therapeutics AG (CRSP:NYSE), 0 | CRISPR Therapeutics AG (CRSP:NAS), 0 | DEXCOM (DXCM:NYSE), 0 | DexCom, Inc. (DXCM:NAS), 0 | Eli Lilly and Co (LLY:NYSE), 0 | Eli Lilly and Company (LLY:NYS), 0 | Hims & Hers Health, Inc. Class A (HIMS:NYS), 0 | INSULET (PODD:NYSE), 0 | Insulet Corporation (PODD:NAS), 0 | Kadimastem Ltd. (KDST:TAE), 0 | Medtronic plc. Ordinary Shares (MDT:NYSE), 0 | Medtronic Plc (MDT:NYS), 0 | NLS Pharmaceutics Ltd. (NLSP:NAS), 0 | Oramed Pharmaceuticals Incorporated (ORMP:TAE), 0 | Sana Biotechnology, Inc. (SANA:NAS), 0 | Sanofi (SAN:EPA), 0 | Sanofi SA (SAN:PAR), 0 | Senseonics Holdings Inc (SENS:NYSE), 0 | Senseonics Holdings, Inc. (SENS:ASE), 0 | Tandem Diabetes Care Inc (TNDM:NYSE), 0 | Tandem Diabetes Care, Inc. (TNDM:NAS), 0 | Teladoc (TDOC:NYSE), 0 | Teladoc Health, Inc. (TDOC:NYS), 0 | Tiziana Life Sciences Ltd. (TLSA:NAS), 0 | VERTEX PHARMACEUTICALS (VRTX:NYSE), 0 | Vertex Pharmaceuticals Incorporated (VRTX:NAS), 0

  • Published: 29 May 2025
  • Author: Research Team ACF
  • Pages: 15
  • ACF Equity Research


We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of merged metrics prior to any synergies. The merger creates a cross-platform pre-revenue biotech with lead programs including a proprietary stem-differentiation platform capable of delivering scalable therapies for replacing lost or damaged cells; IsletRx could revolutionize insulin production for Type 1 diabetes (T1D) patients; AstroRx® targets neurod ....


More Content

More Content

ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial

Companies: ORAMED PHARMACEUTICALS (ORMP:NYSE)Oramed Pharmaceuticals Incorporated (ORMP:NAS)

Zacks Small Cap Research

Nothing new – strong Genzyme but weak diabetes and fledgling Praluent

Companies: Sanofi SA

AlphaValue

Attractive Eli Lilly (LLY) Credit Profile

Companies: Eli Lilly and Company

Yaru Investments

Amgen-Praluent injunction risky

Companies: Sanofi SA

AlphaValue

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innovation 13032025

Companies: LLY SENS CRSP VRTX PODD SAN LLY DXCM TNDM DXCM TDOC MDT TDOC VRTX CRSP KDST MDT SENS NLSP ORMP SAN PODD TLSA HIMS SANA TNDM

ACF Equity Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD (hosted by Progressive)
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In